Clinical Outcomes in Patients With Myelofibrosis Treated With Ruxolitinib and Anemia-Supporting Medications

Poster Presentation
© 2024 American Society of Hematology. All rights reserved.
Meeting: 2024 ASH® Annual Meeting
Indication: Polycythemia Vera (PV)
Presenter: Pankit Vachhani, MD
Affiliation: University of Alabama at Birmingham, Birmingham, AL
Presentation Date: December 9, 2024
Abstract Number: 4546
Session: Session: 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster III
Related content: Polycythemia Vera (PV)
Poster Presentation
Abstract Number: 3136
Presenter: Abdulraheem Yacoub, MD
Indication: Polycythemia Vera (PV)
Date Presented: December 8, 2024
Poster Presentation
Abstract Number: 3145
Presenter: Stephen T. Oh, MD, PhD
Indication: Polycythemia Vera (PV)
Date Presented: December 8, 2024

To access this content please accept the following declarations.

This content was selected by and is provided to you upon your unsolicited request courtesy of Novartis with permission of ASH®.